Picture of Longeveron logo

LGVN Longeveron Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Annual cashflow statement for Longeveron, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-17-18.8-21.4-16-22.7
Depreciation
Non-Cash Items7.583.732.542.391.77
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1.090.238-1.08-1.241.06
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities-9.64-14-19-13.9-18.6
Capital Expenditures-1.31-0.856-0.694-0.992-0.595
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-9.390.1798.880.3520
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-10.7-0.6778.19-0.64-0.595
Financing Cash Flow Items18-0.5115.16-0.366-0.311
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities45.2-0.5095.2628.84.67
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash24.8-15.2-5.5514.3-14.6